Boehringer Ingelheim
Quick facts
Marketed products
- Jardiance · Metabolic · revenue 6500
SYNJARDY combines empagliflozin, which inhibits SGLT2 to increase urinary glucose excretion, and metformin HCl, which improves glucose tolerance and insulin sensitivity. - Spiriva · Respiratory · revenue 2500
Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways. - Ofev · Oncology · revenue 2000
Ofev works by blocking enzymes that promote fibrosis and tumor growth. - Dabigatran Etexilate · Cardiovascular · revenue 1200
Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process. - Tradjenta · Metabolic · revenue 800
Tradjenta works by blocking the DPP-4 enzyme, which normally breaks down incretin hormones that help regulate blood sugar levels. - Tradjenta · Metabolic · revenue 800
Tradjenta works by blocking an enzyme that breaks down hormones that help the body release insulin. - Gilotrif · Oncology · revenue 400
Gilotrif works by blocking the epidermal growth factor receptor, a protein that helps cancer cells grow. - Spevigo · Immunology · revenue 300
Spevigo works by blocking the interleukin-36 receptor, which plays a key role in the development of psoriasis symptoms. - CYLTEZO · Oncology
- Aggrenox · Other
- Amlodipin · Cardiovascular
- Amlodipine 10
- Angiotensin-Converting Enzyme Inhibitors
- Bendrofluazide · Cardiovascular
- Beta-blockers
- Buscopan®
- Catapres-TTS-1
- Combivent Respimat via tee adapter
- Pradaxa · Cardiovascular
Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development. - Dabigatran etexilate powder
- Persantine · Cardiovascular
Persantine works by inhibiting platelet activation and aggregation by blocking the equilibrative nucleoside transporter 1. - Duloxetine - low dose
- Foradil · Other
- Formoterol 12 mcg
- High dose of Micardis®, once daily
- High dose of telmisartan
- Praxbind · Metabolic
Idarucizumab reverses dabigatran's anticoagulant effect by binding to it and its metabolites with high affinity. - ipratropium plus salbutamol UDV
- Maalox · Other
- Mobic · Immunology
Meloxicam works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in the production of prostaglandins that cause pain and inflammation. - Metformin hydrochlorid
- Mexitil · Metabolic
Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat. - Jascayd · Immunology
Jascayd works by inhibiting the activity of phosphodiesterase 4, an enzyme involved in the inflammatory response. - Viramune · Immunology
Viramune works by binding to the reverse transcriptase enzyme, preventing HIV from replicating. - OFEV® · Oncology
- Striverdi Respimat · Respiratory
Striverdi Respimat works by stimulating the beta-2 receptors in the lungs to relax airway muscles and improve breathing. - Fenmetrazina · Metabolic
- Pioglitazone 15 mg
- Pramipexole IR tablet
- Requip · Neuroscience
Phase 3 pipeline
- Elontril · Metabolic
- Faldaprevir: 24-week treatment
Phase 2 pipeline
- BIBW 2992 plus TMZ
- BIIL 284 BS low dose
- Ginsana · Other
- GIOTRIF 30mg
- Gladem · Other
- Micamlo · Other
- Pirfenidoneone · Other
- Prazaxa · Other
- Spiolto · Other
- Trazenta · Other
Phase 1 pipeline
- [13C]-labeled BI 1584862
- [14C]-BI 201335 NA radiolabelled drug
- B: BI 10773 tablet and metformin tablet
- BI 1005273 s.c.
- BI 10773 - single rising dose
- BI 11634 IR tablet
- BI 1387446 200 μg
- BI 2536 BS, intravenous
- BI 3000202_low dose
- BI 3032950
- BI 3814916
- BI 44370 medium dose
- BI 44847
- BI 653048 BS H3PO4
- BI 671800 HEA particulate
- BI 690517 formulation 2
- BI 764198 - Formula D
- BI 765128
- BI 894999
- BIBV 308 SE solution
- BIBW 2948 BS for oral inhalation
- BIBW 2992 high dose 6 day
- BIBX 245 CL- fasted
- BIIL 284 BS, low dose, adult patients
- BIIX 1 XX - single rising dose
- Brotizolam tablet
- Dabigatran etexilate pellets
- Dextromethorphan soft pastilles
- Dextromethorphan syrup - high dose
- Linagliptin Single Tablet
- Low dose of ritonavir
- Merck Glucophage® high dose
- Persantin · Cardiovascular
- R2: Reference Product Y
- Radiolabelled erythromycin
- Salmeterol capsule - high
- Salmeterol MDI high
- Spesolimap · Other
- T3 - High dose of BI 655130
- T5: Test Product P
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Boehringer Ingelheim
What are Boehringer Ingelheim's marketed drugs?
Top marketed products include Jardiance, Spiriva, Ofev, Dabigatran Etexilate, Tradjenta, Tradjenta.
What is Boehringer Ingelheim's pipeline?
Boehringer Ingelheim has 2 drugs in Phase 3, 10 in Phase 2, 43 in Phase 1. Late-stage candidates include Elontril, Faldaprevir: 24-week treatment.
Related
- Jardiance · Metabolic
- Spiriva · Respiratory
- Ofev · Oncology
- Dabigatran Etexilate · Cardiovascular
- Tradjenta · Metabolic
- Sector hub: All tracked pharma companies